OSE OSE Immunotherapeutics SA

2.160EUR+3.45%Mkt Cap: 58.06M $P/E: —

OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. The company's products include Tedopi tha…

HeadlineSourceTime
This week
TradingView
Older
Zonebourse
TradingView
IIdeal Investisseur
ABC Bourse
Zonebourse
Boursier.com
boursedirect.fr
GlobeNewswire
Boursorama
Yahoo Finance France
Idéal Investisseur
Investing.com France
Idéal Investisseur
Boursier.com
GlobeNewswire
Boursorama
Yahoo Finance France
zonebourse.com
Idéal Investisseur
ABC Bourse
Zonebourse
Zonebourse Suisse
Fortuneo
Fortuneo
Yahoo Finance France
Boursorama
Yahoo Finance France
Orange Actualités
Idéal Investisseur
Boursorama
Boursorama
Yahoo Finance France
GlobeNewswire
GlobeNewswire
GlobeNewswire
Zonebourse
TradingView
Idéal Investisseur
Yahoo Finance France
Idéal Investisseur
Yahoo Finance France
Orange Actualités
Orange Actualités
Orange Actualités
TradingView